Overview on the use of recombinant humanized thyroid stimulating hormone (rhTSH) in the treatment and follow-up of patients with thyroid cancer

被引：0
|
作者：
Koutsikos, John
Velidaki, Antigoni
机构：
来源：
JOURNAL OF NUCLEAR MEDICINE | 2015年 / 56卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1898
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Recombinant human thyroid-stimulating hormone as an alternative for thyroid hormone withdrawal in thyroid cancer management
    Chen, Ming-Kai
    Doddamane, Indukala
    Cheng, David W.
    CURRENT OPINION IN ONCOLOGY, 2010, 22 (01) : 6 - 10
  • [22] Treatment and follow-up of low-risk patients with thyroid cancer
    Schlumberger, Martin
    Borget, Isabelle
    Nascimento, Camila
    Brassard, Maryse
    Leboulleux, Sophie
    NATURE REVIEWS ENDOCRINOLOGY, 2011, 7 (10) : 625 - 628
  • [23] Treatment and follow-up of low-risk patients with thyroid cancer
    Martin Schlumberger
    Isabelle Borget
    Camila Nascimento
    Maryse Brassard
    Sophie Leboulleux
    Nature Reviews Endocrinology, 2011, 7 : 625 - 628
  • [24] Follow-up of differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after recombinant human thyrotropin or thyroid hormone withdrawal.
    Elisei, R.
    Corone, C.
    Driedger, A.
    Haugen, B.
    Kloos, R.
    Magner, J.
    Pacini, F.
    Luster, M.
    Schlumberger, M.
    Sherman, S.
    Pinchera, A.
    Ladenson, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S207 - S208
  • [25] The use of Recombinant Human Thyrotropin (rhTSH) in the Management of Differentiated Thyroid Cancer
    Skarulis M.C.
    Reviews in Endocrine and Metabolic Disorders, 2000, 1 (3) : 147 - 154
  • [26] Metastatic differentiated thyroid cancer in paediatric patients - radioiodine treatment after thyroid hormone withdrawal or rhTSH stimulation
    Handkiewicz-Junak, D.
    Kropinska, A.
    Ledwon, A.
    Roskosz, J.
    Kula, D.
    Kluczewska, A.
    Olczyk, T.
    Paliczka, E.
    Puch, Z.
    Jarzab, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S120 - S121
  • [27] Use of recombinant human thyroid-stimulating hormone in the management of well-differentiated thyroid cancer
    Kraenzlin, ME
    Meier, C
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2006, 6 (02) : 167 - 176
  • [28] Recombinant human thyroid stimulating hormone in 2008: focus on thyroid cancer management
    Gramza, Ann
    Schuff, Kathryn G.
    ONCOTARGETS AND THERAPY, 2008, 1 : 87 - 101
  • [29] FOLLOW-UP OF PATIENTS WITH DIFFERENTIATED THYROID-CANCER
    MULLERGARTNER, HW
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1987, 112 (08) : 326 - 326
  • [30] Follow-up of thyroid cancer patients with "poor prognosis"
    Toubert, ME
    ANNALES D ENDOCRINOLOGIE, 2003, 64 (01) : 68 - 71
12345